Anpario plc (AIM:ANP)

Market Cap	102.98M
Revenue (ttm)	43.93M
Net Income (ttm)	5.15M
Shares Out	20.60M
EPS (ttm)	0.30
PE Ratio	16.82
Forward PE	15.75
Dividend	0.11 (2.25%)
Ex-Dividend Date	Nov 13, 2025

Volume	12,601
Average Volume	47,130
Open	507.70
Previous Close	500.00
Day's Range	495.50 - 507.70
52-Week Range	286.00 - 520.00
Beta	0.68
RSI	70.18
Earnings Date	Sep 10, 2025

About Anpario

Anpario plc, together with its subsidiaries, manufactures and distributes natural animal feed additives for animal health, nutrition, and biosecurity. Its health and performance category offers various products that support and maintain animal gut health, including phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzy...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1996
• Employees: 157
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ANP

Financial Performance

In 2024, Anpario's revenue was 38.20 million, an increase of 23.22% compared to the previous year's 31.00 million. Earnings were 4.11 million, an increase of 62.66%.